97
Views
15
CrossRef citations to date
0
Altmetric
Study design

Improving efficiency of ALS clinical trials using lead‐in designs

Pages 57-60 | Published online: 10 Jul 2009
 

Abstract

We describe designs for clinical trials in ALS including two that are more efficient than the standard two‐arm, parallel design. The more efficient designs incorporate a lead‐in period followed by a randomized intervention (drug or placebo) period. Efficacy of the more efficient designs is based on measuring, within each patient, the difference in slope while on the new treatment compared to the lead‐in period. We demonstrate, with sample size calculations, that the lead‐in designs are considerably more efficient than the standard two‐arm, parallel design. Sample sizes can be reduced by 44% for a 12‐month study using ALSFRS rate of decline as a primary endpoint for a two‐arm trial with 4 months lead‐in compared to a parallel design. A sample size reduction of 70% can be realized with variable lead‐in compared to a parallel design.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.